Ophthalmology PACS (Picture Archiving and Communication System) Market Worth $160.2 Million by 2023

Wednesday, August 8, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

PUNE, India, August 8, 2018 /PRNewswire/ --

According to a new market research report "Ophthalmology PACS (Picture Archiving and Communication System) Market

 by Type (Standalone, Integrated), Delivery (On-premise, Cloud), End User (Hospitals, Specialty Clinic, ASC), Region (North America (US, Canada) Europe, Asia) - Global Forecast to 2023
", published by MarketsandMarkets™, the global market is projected to reach USD 160.2 million by 2023 from an estimated USD 106.6 million in 2018, at a CAGR of 8.5% during the forecast period.

     (Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )

Browse 86 market data Tables and 33 Figures spread through 134 Pages and in-depth TOC on "Ophthalmology PACS (Picture Archiving and Communication System) Market"


Early buyers will receive 10% customization on this report 

Rapid growth in the geriatric population, rising prevalence of eye diseases, limited number of ophthalmologists, government initiatives to encourage the adoption of EHR/EMR, and the increasing adoption of teleophthalmology are the factors driving the growth of the Ophthalmology PACS Market.

The integrated PACS segment is expected to dominate the Ophthalmology PACS Market in 2018. 

Based on type, the Ophthalmology PACS Market is segmented into standalone and integrated PACS. Among these, the integrated PACS segment is expected to command the largest share of the Ophthalmology PACS Market in 2018. The advantages associated with the use of integrated PACS, such as ease of deployment and use, easy interoperability, data security, portability, and cost-effectiveness are driving the growth of this segment.

Based on delivery model, the web/cloud-based PACS segment is projected to grow at the highest CAGR during the forecast period. 

Based on delivery model, the Ophthalmology PACS Market is segmented into on-premise and web/cloud-based models. The web/cloud-based PACS segment is expected to grow at the highest CAGR during the forecast period. The high growth rate can be attributed to the fact that, these models do not require any significant setup charges. Maintenance and support service charges are also included in subscription fees, which make these delivery models more affordable for customers.

The specialty clinics & ambulatory surgery centers segment is expected to dominate the Ophthalmology PACS Market in 2018. 

Based on end user, the Ophthalmology PACS Market is segmented into hospitals, specialty clinics & ambulatory surgery centers, and other end users. In 2018, the specialty clinics & ambulatory surgical centers segment is expected to command the largest share of the Ophthalmology PACS Market. The growing patient pool for the diagnosis and treatment of cataracts in specialty clinics & ASCs due to cost-effective treatments is expected to propel the growth of the Ophthalmology PACS Market in this end-user segment.

Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=130879968

North America to dominate the market in 2018 

In 2018, North America is expected to command the largest share of the market. With the growing aging population and increasing incidence of age-related eye diseases, the demand for technologies such as PACS is increasing in the North American region. Additionally, government initiatives towards digitization and increasing adoption of EHR/EMR and data storage & exchange solutions are the additional factors driving the adoption of ophthalmology PACS in this region.

While the Ophthalmology PACS Market represents significant growth opportunities, market growth may be hindered due to the high implementation and maintenance costs of these solutions. The Ophthalmology PACS Market is marked by the presence of several big and small players. Prominent players in this market include Carl Zeiss Meditec AG (Germany), Topcon Corporation (Japan), Heidelberg Engineering (Germany), Sonomed Escalon (US), Visbion (UK), EyePACS (US), and IBM Corporation (Merge Healthcare) (US).

Know more about the Ophthalmology PACS Market: 


About MarketsandMarkets™  

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/ophthalmology-pacs-market.asp

Connect with us on LinkedIn: http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store